In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GSK gets exclusive marketing rights to Medivir's Xerclear

Executive Summary

Infectious disease-focused Medivir AB has licensed GlaxoSmithKline PLC exclusive rights to commercialize its over-the-counter Xerclear (acyclovir/hydrocortisone) cold sore cream in key markets including Europe, Japan, India, Australia, and New Zealand. (North and South America, China, South Korea, and Israel are excluded in the agreement.)
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Marketing (Licensing)

Related Companies